Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor

被引:113
作者
Tan, Eng M. [1 ]
Smolen, Josef S. [2 ]
机构
[1] Scripps Res Inst, La Jolla, CA 92037 USA
[2] Med Univ Vienna, Dept Med 3, Div Rheumatol, A-1090 Vienna, Austria
基金
美国国家卫生研究院;
关键词
EPSTEIN-BARR-VIRUS; CYCLIC CITRULLINATED PEPTIDE; POLYMERASE-CHAIN-REACTION; BLOOD MONONUCLEAR-CELLS; NECROSIS-FACTOR-ALPHA; NUCLEAR ANTIGEN; SYNOVIAL-FLUIDS; SJOGRENS-SYNDROME; ANTIPERINUCLEAR FACTOR; IMMUNE-COMPLEXES;
D O I
10.1084/jem.20160792
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
When studies on rheumatoid arthritis (RA) that were made many decades ago and could be considered "historical" in nature are analyzed in the context of recent observations, important insights on RA and on the function of rheumatoid factor (RF) become apparent. RF in the role of antibody to immune complexes (ICs) appears to be involved in activation of the complement system and in the production of chemotactic and inflammatory mediators, creating a condition that can be sustained and reinitiated. In the synovial cavity, a state of nonresolving inflammation is produced with the formation of citrullinated protein antigen-antibody complexes or other forms of ICs. This is followed by a second wave of IC production in the form of RF acting as antibody reactive with the initial ICs. Both of these processes are associated with complement consumption and production of inflammatory mediators. We present a model of an initiation phase of RA that might represent an example of repetitive formation of ICs and complement-mediated inflammation. Targeting therapy at this phase of RA to break the cycles of recurrent inflammation might be a novel approach to aid in further control of the disease.
引用
收藏
页码:1937 / 1950
页数:14
相关论文
共 133 条
[1]
Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis [J].
Abdel Fattah N.S. ;
Hassan H.E. ;
Galal Z.A. ;
El Okda E.S.E. .
BMC Research Notes, 2 (1)
[2]
HUMAN-IGG RHEUMATOID FACTORS AND RF-LIKE IMMUNE-COMPLEXES INDUCE IGG1 RHEUMATOID-FACTOR PRODUCTION IN MICE [J].
ABEDIVALUGERDI, M ;
RIDDERSTAD, A ;
ALBALAGHI, S ;
MOLLER, E .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 41 (06) :575-582
[3]
INDUCTION OF A RHEUMATOID FACTOR-LIKE SUBSTANCE IN RABBITS [J].
ABRUZZO, JL ;
CHRISTIAN, CL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1961, 114 (05) :791-&
[4]
AHO K, 1991, J RHEUMATOL, V18, P1282
[5]
AHO K, 1993, J RHEUMATOL, V20, P1278
[6]
CHARACTERISTICS OF ANTI-NUCLEAR ANTIBODIES IN RHEUMATOID-ARTHRITIS - REACTIVITY OF RHEUMATOID-FACTOR WITH A HISTONE-DEPENDENT NUCLEAR ANTIGEN [J].
AITCHESON, CT ;
PEEBLES, C ;
JOSLIN, F ;
TAN, EM .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :528-538
[7]
Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials [J].
Aletaha, Daniel ;
Alasti, Farideh ;
Smolen, Josef S. .
ARTHRITIS RESEARCH & THERAPY, 2015, 17
[8]
Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity [J].
Aletaha, Daniel ;
Alasti, Farideh ;
Smolen, Josef S. .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (06) :875-880
[9]
LYMPHOCYTES TRANSFORMED BY EPSTEIN-BARR VIRUS - INDUCTION OF NUCLEAR ANTIGEN REACTIVE WITH ANTIBODY IN RHEUMATOID-ARTHRITIS [J].
ALSPAUGH, MA ;
JENSEN, FC ;
RABIN, H ;
TAN, EM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 147 (04) :1018-1027
[10]
ALSPAUGH MA, 1976, ARTHRITIS RHEUM-US, V19, P711, DOI 10.1002/1529-0131(197607/08)19:4<711::AID-ART1780190409>3.0.CO